U.S. Ophthalmic Sutures Market Analysis

U.S. Ophthalmic Sutures Market Analysis

U.S. natural ophthalmic sutures market share is expected to reach around USD 163 million through 2032. These sutures offer adequate strength, can perform self-degradation absorption, and possess non-irritating and carcinogenic characteristics. Moreover, these natural sutures are easy to produce at low cost along with mass production. Natural ophthalmic sutures are considerably recommended in related surgical procedures attributable to good absorption, strong pull, and support wound healing characteristics. Hence, the regional product demand will be influenced by these distinct product traits.
 

U.S. ophthalmic sutures market share from the coated segment is expected to grow with more than 5% CAGR by 2032. Suture coating is known to lessen friction for ease of tissue passage and provides enhanced suture flexibility. This coating material delivers accurate consistent suture tension and holds tensile strength and can also be coated with antibiotics that make them more infection resistant. Coating serves the purpose of modifying the surface that enhances precision and penetration. The current antibiotics used by market players are showing sufficient effectiveness against bacterial resistance. Thus, these coated sutures can be touted as evaluated promising tools in the fight against surgical site infections.
 

The industry size from the cataract surgery segment is anticipated to record more than 5.5% CAGR through 2032. Growing occurrence of cataract disease is driving the market growth. For instance, in 2021, around 10,000 U.S. cataract surgeons performed around 4 million procedures in the U.S. Some of the key variables driving the market growth are rising accessibility to innovative technologies that boost the quality of cataract surgery coupled with the presence of board-certified skilled surgeons. Moreover, continuous advancements and development in ophthalmic sutures used in these procedures will positively impact the industry expansion.
 

U.S. ophthalmic sutures market share from the hospital segment held dominant market share in 2022 and is projected to touch USD 297 million through 2032. Increasing number of ophthalmic surgical procedures performed at hospital settings will foster the segmental progression. Moreover, surging number of patients that require critical care along with rising availability of better healthcare infrastructure will propel the market growth. The ease of access to a wide range of surgical treatments, medical evaluation for various ailments, and hygienic conditions in the country are some factors contributing to the industry progression.